» Articles » PMID: 31521709

New Insights into Progesterone Actions on Prolactin Secretion and Prolactinoma Development

Overview
Journal Steroids
Publisher Elsevier
Specialty Biochemistry
Date 2019 Sep 16
PMID 31521709
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Progesterone (P4) has controversial physiological effects on the regulation of the lactotroph population. While some studies have shown a negative role for P4 in prolactin secretion and lactotroph proliferation, antagonizing estradiol effects, others demonstrated a proliferative role of P4 at the pituitary level. Usually, progesterone actions in the pituitary gland were studied through their classical, genomic pathways triggered by nuclear progesterone receptors (nPRs). However, in 2003, the scene became more complex with the discovery of another group of progesterone receptors involved in rapid, non-genomic P4 effects: the membrane progesterone receptors (mPRs), which are members of the progesterone and adipoQ receptor (PAQR) family. This review examines the historical background and current data on the study of progesterone actions on PRL secretion providing new evidence of P4 effects at the hypothalamic and at the pituitary level through non-classic P4-receptors. In addition, we explore the role of progesterone in the development of experimental prolactinomas, a controversial topic in the literature.

Citing Articles

Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment.

Dzialach L, Sobolewska J, Zak Z, Respondek W, Witek P Front Endocrinol (Lausanne). 2024; 15:1338345.

PMID: 38370355 PMC: 10870150. DOI: 10.3389/fendo.2024.1338345.


Revealing Sexual Dimorphism in Prolactin Regulation From Early Postnatal Development to Adulthood in Murine Models.

Abeledo-Machado A, Pena-Zanoni M, Bornancini D, Diaz-Torga G J Endocr Soc. 2023; 8(1):bvad146.

PMID: 38045876 PMC: 10690727. DOI: 10.1210/jendso/bvad146.


Metabolomic Profiling of Female Mink Serum during Early to Mid-Pregnancy to Reveal Metabolite Changes.

Luo Y, Huang Y, Deng L, Li Z, Li C Genes (Basel). 2023; 14(9).

PMID: 37761899 PMC: 10531253. DOI: 10.3390/genes14091759.


Approach to the Patient With Prolactinoma.

Auriemma R, Pirchio R, Pivonello C, Garifalos F, Colao A, Pivonello R J Clin Endocrinol Metab. 2023; 108(9):2400-2423.

PMID: 36974474 PMC: 10438891. DOI: 10.1210/clinem/dgad174.


Prolactin and oxytocin: potential targets for migraine treatment.

Szewczyk A, Ulutas S, Akturk T, Al-Hassany L, Borner C, Cernigliaro F J Headache Pain. 2023; 24(1):31.

PMID: 36967387 PMC: 10041814. DOI: 10.1186/s10194-023-01557-6.